WCM
PCRX icon

Weld Capital Management’s Pacira BioSciences PCRX Stock Holding History

Weld Capital Management’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,560
Closed -$213K – 494
2020
Q4 		$213K Buy
+3,560
New +$208K 0.08% 382
2020
Q3 		– Sell
-37,507
Closed -$1.97M – 622
2020
Q2 		$1.97M Buy
+37,507
New +$1.57M 0.77% 9
2019
Q3 		– Sell
-8,745
Closed -$380K – 945
2019
Q2 		$380K Buy
+8,745
New +$371K 0.07% 470

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.85B AUM 15.7% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Weld Capital Management's PCRX Position: Q1 2021 in Review

Weld Capital Management sold out of Pacira BioSciences (PCRX) in Q1 2021, closing a stake of 3,560 shares — an estimated $213K sold.

Weld Capital Management first reported a position in PCRX in Q2 2019 and held it in 3 quarters. The position peaked at $1.97M in Q2 2020. 270 funds tracked by Wall St. Rank hold PCRX as of Q1 2021.

  • Weld Capital Management reported no remaining Pacira BioSciences position as of Q1 2021 after selling out during the quarter.
  • Weld Capital Management sold 3,560 Pacira BioSciences shares in Q1 2021, an estimated $213K.
  • Weld Capital Management first reported a position in Pacira BioSciences in Q2 2019 and held it in 3 quarters.
  • Weld Capital Management's Pacira BioSciences position peaked at $1.97M in Q2 2020.
  • 270 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2021.

Based on Weld Capital Management's 13F filing for Q1 2021, filed 17 May 2021.